Figure S5 from Antitumor Immune Responses in B2M-Deficient Cancers
Year: 2023
Type: other
Abstract: (A) T cell subsets and (B) myeloid and dendritic cell subsets in MC38 with and without B2M expression. Differences in the infiltration of immune cells in MC38 WT and B2M-KO tumors. Tumors were collected on day 9 (two doses of isotype or a-PD-1) and day 16 (four doses of isotype or a-PD-1). (C) Numbers of CD8+ T, CD4+ T and NK cells per gram in MC38 WT and B2M-KO tumors. Mean ± SEM, Unpaired t test, n = 6. ns, not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001*.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4389242245